Regencell Bioscience Holdings Limited - (RGC) closed at $5.27 on November 6, 2026, unchanged from the previous close, on volume of 189,203 shares (30-day average 320,384).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 20, 2026 | Calendar Put Spread | 18-Dec-26 : 17-Jun-27 15 P | 400 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
No press releases found.
DOJ Investigation Spurs Renewed Focus on Regencell: What Investors Should Know
Market Chameleon (Fri, 9-Jan 6:15 AM ET)
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
Regencell Bioscience Holdings Limited - trades on the NASDAQ stock market under the symbol RGC.
As of November 6, 2026, RGC stock price was flat at $5.27 with 189,203 million shares trading.
RGC has a beta of 2.42, meaning it tends to be more sensitive to market movements. RGC has a correlation of 0.04 to the broad based SPY ETF.
RGC has a market cap of $2.61 billion. This is considered a Mid Cap stock.
In the last 3 years, RGC traded as high as $83.60 and as low as $.08.
The top ETF exchange traded funds that RGC belongs to (by Net Assets): ONEQ, GXC.
RGC has underperformed the market in the last year with a price return of -60.3% while the SPY ETF gained +10.8%. However, in the short term, RGC had mixed performance relative to the market. It has outperformed in the last 3 months, returning -3.5% vs -4.1% return in SPY. But in the last 2 weeks, RGC shares have been beat by the market, returning -31.3% compared to an SPY return of -3.2%.
RGC support price is $4.69 and resistance is $5.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RGC shares will trade within this expected range on the day.
